Congenital Heart Disease Treatment Device Market

Congenital heart disease (CHD) is a cardiovascular malformation caused by abnormal fetal heart and blood vessel development, and it is one of the most common congenital malformations.

Congenital Heart Disease Treatment Device Market contains market size and forecasts of Congenital Heart Disease Treatment Device in global, including the following market information:

• Global Congenital Heart Disease Treatment Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Congenital Heart Disease Treatment Device Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Congenital Heart Disease Treatment Device companies in 2021 (%)

The global Congenital Heart Disease Treatment Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Artificial Heart Valve Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Congenital Heart Disease Treatment Device include Abbott, Medtronic plc, Beijing Balance Medical Technology, Med-Zenith, MicroPort, Weigao Holding Company Limited, CryoLife and Edwards LifeSciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Congenital Heart Disease Treatment Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Congenital Heart Disease Treatment Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Congenital Heart Disease Treatment Device Market Segment Percentages, by Type, 2021 (%)

• Artificial Heart Valve
• Bracket
• Ventricular Assist Device (VAD)
• Other

Global Congenital Heart Disease Treatment Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Congenital Heart Disease Treatment Device Market Segment Percentages, by Application, 2021 (%)

• Adult
• Children

Global Congenital Heart Disease Treatment Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Congenital Heart Disease Treatment Device Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Congenital Heart Disease Treatment Device revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Congenital Heart Disease Treatment Device revenues share in global market, 2021 (%)
• Key companies Congenital Heart Disease Treatment Device sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Congenital Heart Disease Treatment Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Medtronic plc
• Beijing Balance Medical Technology
• Med-Zenith
• MicroPort
• Weigao Holding Company Limited
• CryoLife
• Edwards LifeSciences